Side-by-side comparison of AI visibility scores, market position, and capabilities
Peer-to-peer sports prediction exchange with $2B+ annualized trading volume; $24.4M raised from Forerunner Ventures offering exchange-model odds without sportsbook house edge.
Novig is a peer-to-peer sports prediction market platform where users trade directly against each other on sporting event outcomes — rather than betting against a traditional sportsbook house that takes margin on every wager, Novig's exchange model matches bettors with opposing positions, charging a small commission on winning trades. Founded in 2022 and backed by $24.4 million total including an $18 million Series A led by Forerunner Ventures, Novig launched in September 2024 and achieved $2 billion+ in annualized trading volume with 90%+ of trades occurring peer-to-peer and user retention 3x higher than traditional sportsbooks.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.